AU2011276479B2 - Methods and compositions for enhancing stem cell mobilization - Google Patents

Methods and compositions for enhancing stem cell mobilization Download PDF

Info

Publication number
AU2011276479B2
AU2011276479B2 AU2011276479A AU2011276479A AU2011276479B2 AU 2011276479 B2 AU2011276479 B2 AU 2011276479B2 AU 2011276479 A AU2011276479 A AU 2011276479A AU 2011276479 A AU2011276479 A AU 2011276479A AU 2011276479 B2 AU2011276479 B2 AU 2011276479B2
Authority
AU
Australia
Prior art keywords
extracts
fucoidan
stem cells
stem cell
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011276479A
Other languages
English (en)
Other versions
AU2011276479A1 (en
Inventor
Christian Drapeau
Gitte S. Jensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stemtech International Inc
Original Assignee
Stemtech International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemtech International Inc filed Critical Stemtech International Inc
Publication of AU2011276479A1 publication Critical patent/AU2011276479A1/en
Application granted granted Critical
Publication of AU2011276479B2 publication Critical patent/AU2011276479B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/066—Clavicipitaceae
    • A61K36/068—Cordyceps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2011276479A 2010-06-28 2011-06-28 Methods and compositions for enhancing stem cell mobilization Ceased AU2011276479B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US35928810P 2010-06-28 2010-06-28
US61/359,288 2010-06-28
US201061427023P 2010-12-23 2010-12-23
US61/427,023 2010-12-23
PCT/US2011/042211 WO2012006100A2 (en) 2010-06-28 2011-06-28 Methods and compositions for enhancing stem cell mobilization

Publications (2)

Publication Number Publication Date
AU2011276479A1 AU2011276479A1 (en) 2013-01-17
AU2011276479B2 true AU2011276479B2 (en) 2015-06-25

Family

ID=45441732

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011276479A Ceased AU2011276479B2 (en) 2010-06-28 2011-06-28 Methods and compositions for enhancing stem cell mobilization

Country Status (10)

Country Link
US (1) US10159705B2 (enExample)
EP (2) EP2588119A4 (enExample)
JP (2) JP2013531012A (enExample)
KR (1) KR20140011295A (enExample)
AU (1) AU2011276479B2 (enExample)
BR (1) BR112012033548A2 (enExample)
MX (1) MX344304B (enExample)
MY (1) MY170013A (enExample)
WO (1) WO2012006100A2 (enExample)
ZA (1) ZA201300101B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9327003B2 (en) 2011-11-18 2016-05-03 Stemtech International, Inc. Use of foti to enhance stem cell mobilization and proliferation
US10159705B2 (en) 2010-06-28 2018-12-25 Stemtech IP Holdings, LLC Methods and compositions for enhancing stem cell mobilization

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
LT2846809T (lt) 2012-05-09 2021-01-25 Cantex Pharmaceuticals, Inc. Mielosupresijos gydymas
JP6050033B2 (ja) * 2012-06-05 2016-12-21 日本メナード化粧品株式会社 幹細胞から外胚葉系細胞への分化誘導剤
HK1210501A1 (zh) * 2012-07-11 2016-04-22 Stemtech International, Inc. 增进胚胎样干细胞活力及增殖的组合物及方法
CN104822827B (zh) 2012-12-06 2020-01-21 干细胞生物科技公司 Lgr5+体干细胞
EP2746770A1 (en) * 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
SG11201509437XA (en) * 2013-06-19 2015-12-30 Stemtech International Inc Methods and compositions for enhancing stem cell mobilization
EP2818544A1 (en) * 2013-06-24 2014-12-31 Stembios Technologies, Inc. Method for counting number of stem cells in human or animal samples
US20150141901A1 (en) * 2013-11-08 2015-05-21 Alan S. Lichtbroun Low-level laser irradiation of stimulated human stem cells
US10052346B2 (en) 2015-02-17 2018-08-21 Cantex Pharmaceuticals, Inc. Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids
US20160243168A1 (en) * 2015-02-17 2016-08-25 Cantex Pharmaceuticals, Inc. Adoptive cell transfer methods
EP3853356A4 (en) 2018-09-20 2022-09-14 Mystem Biotechnologies Inc. STEM CELLS DERIVED FROM COLOSTRUM, NEURONAL DIFFERENTIATION, COMPOSITIONS AND SUPPLEMENTS FOR IMPROVING MAMMALIAN HEALTH
CN109432028A (zh) * 2018-11-30 2019-03-08 广东乾禾药用植物发展有限公司 一种猴头菌胃漂浮片的制备方法
JP7205880B2 (ja) * 2018-12-13 2023-01-17 日本メナード化粧品株式会社 メラノサイト分化誘導促進剤及びその使用方法
CN112806569A (zh) * 2021-01-20 2021-05-18 中科优术(黑龙江)科技产业有限公司 一种具有保护胃黏膜和抗幽门螺杆菌功能的组合物的制备方法与应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003135028A (ja) * 2001-07-27 2003-05-13 Social Excellent Community Kk 健康機能食品
JP2003259844A (ja) * 2002-03-12 2003-09-16 Aruga:Kk 海藻を原料とする飲料用食品の製造方法
US20070003669A1 (en) * 2005-06-02 2007-01-04 Troy Kearl Fucoidan delivery system
US20070190023A1 (en) * 2006-01-25 2007-08-16 Michela Battista Methods and compositions for modulating the mobilization of stem cells
KR20080007698A (ko) * 2006-07-18 2008-01-23 전홍일 푸코이단을 포함하는 산후 조리용 식품 조성물
JP2009221133A (ja) * 2008-03-14 2009-10-01 Daiichi Yakuhin Kogyo Kk 抗ウイルス活性強化組成物
US20100144667A1 (en) * 2007-02-23 2010-06-10 Shaklee Patrick N Methods for fucoidan purification from sea weed extracts

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2878597B2 (ja) 1994-04-15 1999-04-05 惇 額田 養毛剤
US6814961B1 (en) 2001-05-14 2004-11-09 Gitte S. Jensen Method for enhancing stem cell trafficking
CN1827766B (zh) 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
US20050042314A1 (en) 2003-08-22 2005-02-24 National Yang-Ming University Extracts of Polygonum multiflorum Thunb., and preparation process and uses of the same
US20060068022A1 (en) 2004-09-29 2006-03-30 Playford Raymond J Bioactive agent compositions for repair of cell injuries
CA2629529A1 (en) 2004-11-18 2006-05-26 Biopharmacopae Design International Inc. Plant extracts and dermatological uses thereof
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
AU2006237738B2 (en) * 2005-04-21 2011-09-29 N.V. Nutricia Nutritional supplement for HIV patients
US20080085330A1 (en) * 2005-05-02 2008-04-10 Cyndy Davis Sanberg Compounds for stimulating stem cell proliferation including spirulina
JP4839021B2 (ja) * 2005-06-10 2011-12-14 国立大学法人 岡山大学 白血球及び／又は造血幹・前駆細胞動員剤
US7651690B2 (en) * 2005-06-24 2010-01-26 Desert Lake Technologies Purified component of blue-green algae and method of use
JP2009538923A (ja) * 2006-06-01 2009-11-12 サクラ プロパティーズ、エルエルシー フコイダン組成物及び方法
EP2099465A4 (en) 2006-09-21 2011-09-14 Academia Sinica IMPROVEMENT BY REISHI OF HUMAN TISSUE PROGENITOR CELLULAR ADHESION AND DIFFERENTIATION
HUP0700594A2 (en) * 2007-09-13 2009-04-28 Laszlo Szabo Composition and process for the protection and increasing the number of stem cells in the blood circulation and for enhancing p53 gene expression
CN101433313B (zh) * 2007-11-13 2012-05-30 蒋爱芳 一种具有抗辐射功能的保健食品
KR20090099374A (ko) * 2008-03-17 2009-09-22 김명숙 후코이단을 보강한 미역추출물 및 그 제조방법
US8871492B2 (en) * 2008-05-02 2014-10-28 Masaki Shirota Anti-dementia substance from Hericium erinaceum and method of extraction
CA2745376A1 (en) 2008-12-01 2010-06-10 Lifespan Extension Llc Methods and compositions for altering health, wellbeing, and lifespan
TW201041586A (en) * 2009-05-22 2010-12-01 Du Peng Medicine and its preparation method for treating Parkinson's disease
US20110287061A1 (en) 2010-05-20 2011-11-24 Cathy Beggan Dietary composition and method for promoting healthy hair growth and melanogenesis
EP2588119A4 (en) 2010-06-28 2014-01-08 Stemtech Internat Inc METHOD AND COMPOSITIONS FOR IMPROVING STRAIN CELL MOBILIZATION
CN103561754A (zh) 2011-03-28 2014-02-05 玫琳凯有限公司 包含植物提取物的局部护肤制剂
US9289375B2 (en) 2011-08-05 2016-03-22 Stemtech International Inc. Skin care compositions containing combinations of natural ingredients
KR20140091674A (ko) 2011-11-18 2014-07-22 스템테크 인터내셔널, 인크. 줄기 세포의 동원 및 증진을 강화하는 foti의 용도
EP2797595A4 (en) 2011-12-29 2015-11-25 Entia Biosciences Inc NUTRITIONAL APPROACH FOR THE USE OF ERGOTHIONEIN AND VITAMIN D2 FOR HAIR, NAIL AND SKIN GROWTH
HK1210501A1 (zh) 2012-07-11 2016-04-22 Stemtech International, Inc. 增进胚胎样干细胞活力及增殖的组合物及方法
SG11201509437XA (en) 2013-06-19 2015-12-30 Stemtech International Inc Methods and compositions for enhancing stem cell mobilization

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003135028A (ja) * 2001-07-27 2003-05-13 Social Excellent Community Kk 健康機能食品
JP2003259844A (ja) * 2002-03-12 2003-09-16 Aruga:Kk 海藻を原料とする飲料用食品の製造方法
US20070003669A1 (en) * 2005-06-02 2007-01-04 Troy Kearl Fucoidan delivery system
US20070190023A1 (en) * 2006-01-25 2007-08-16 Michela Battista Methods and compositions for modulating the mobilization of stem cells
KR20080007698A (ko) * 2006-07-18 2008-01-23 전홍일 푸코이단을 포함하는 산후 조리용 식품 조성물
US20100144667A1 (en) * 2007-02-23 2010-06-10 Shaklee Patrick N Methods for fucoidan purification from sea weed extracts
JP2009221133A (ja) * 2008-03-14 2009-10-01 Daiichi Yakuhin Kogyo Kk 抗ウイルス活性強化組成物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
D1 : IRHIMEH ET AL: "Fucoidan ingestion increases the expression of CXCR4 on human CD34+ cells". Experimental Hematology, 2007, vol. 35, no. 6, pges 989-994. *
D10 : KISS ET AL:"Enhancement of organ regeneration in animal models by a stem cell stimulating plant mixture". Journal of Medicinal Food, June 3 2010 (available online 21 April 2010), vol. 13, no. 3, pages 599-604. *
D4 : Zradical juice [retreived on 3 June 2014] Retrieved from internet <URL: http://escapeyoung.wordpress.com/2009/11/05/talking-about-zradical-juice-has-acai-berry-mangosteenother- healthy-ingredients/ published on Nov 5 2009 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10159705B2 (en) 2010-06-28 2018-12-25 Stemtech IP Holdings, LLC Methods and compositions for enhancing stem cell mobilization
US9327003B2 (en) 2011-11-18 2016-05-03 Stemtech International, Inc. Use of foti to enhance stem cell mobilization and proliferation

Also Published As

Publication number Publication date
ZA201300101B (en) 2014-03-26
MY170013A (en) 2019-06-20
WO2012006100A2 (en) 2012-01-12
AU2011276479A1 (en) 2013-01-17
MX2012015063A (es) 2013-04-03
BR112012033548A2 (pt) 2017-06-20
KR20140011295A (ko) 2014-01-28
US20130108587A1 (en) 2013-05-02
JP2013531012A (ja) 2013-08-01
EP2588119A4 (en) 2014-01-08
EP3153173A1 (en) 2017-04-12
JP2016153430A (ja) 2016-08-25
EP2588119A2 (en) 2013-05-08
US10159705B2 (en) 2018-12-25
WO2012006100A3 (en) 2012-03-15
MX344304B (es) 2016-12-13

Similar Documents

Publication Publication Date Title
AU2011276479B2 (en) Methods and compositions for enhancing stem cell mobilization
US9327003B2 (en) Use of foti to enhance stem cell mobilization and proliferation
Yoo et al. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues
US20160136225A1 (en) Methods and compositions for enhancing stem cell mobilization
US20150182574A1 (en) Compositions and methods for enhancing mobilization and proliferation of blastomere-like stem cells
KR101489728B1 (ko) 남조류의 정제된 성분 및 이용 방법
KR101400900B1 (ko) 탄시논을 유효성분으로 함유하는 자연살해세포 분화 또는 활성 증진용 조성물
Ho et al. The immunostimulating activities of anti-tumor polysaccharide from K1 capsular (polysaccharide) antigen isolated from Klebsiella pneumoniae
US20160374934A1 (en) Methods for treatment of hair graying
US20230084354A1 (en) Nutraceutical extracts of hippophae rhamnoides and terminalia chebula and uses thereof
JP2020512296A (ja) Ｉｌ−６レベルを低減するための体性幹細胞の使用
CA3214433A1 (en) New treatment of sepsis
EP4079312A1 (en) New treatment of sepsis
US20150359827A1 (en) Blue-green algae extract mixtures and methods of use
TW201907926A (zh) 體幹細胞用於增加蛋白質精胺酸甲基轉移酶(prmt)位準的用途

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired